"Patients diagnosed with headache may benefit from concurrent behavioral health evaluation and treatment," researchers said.

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...

Panadol has unveiled sub-brand Panmigrol, aimed at tackling migraine pain.

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

A study published in The Lancet found that sodium nitrite provoked headaches in eight out of 13 people who consumed it.

Professor Sue Astley Theodossiadis has published the final messages and calls sent and made by her 25-year-old son Alex who died after contracting meningitis five years ago.

Ginger acts as a wonderful painkiller, very few people know this, but whenever you have severe pain, you can adopt this as a ...

Medical experts came together to address matters concerning the different types of headaches commonly experienced today.

A warning has been issued to anyone who eats bananas or cheese, as these foods can trigger nasty migraines. Migraines feel ...

Clinical trials demonstrated that a single dose of Symbravo provides rapid migraine relief, sustains efficacy for up to 48 ...

FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast absorption for effective symptom control.